IntegraGen S.A.
ALINT.PA
Get informed when a big investor buys or sells
+ FollowMarket Cap$369.5K
Close$
Share Statistics
| Market cap | $369,498.00 |
|---|---|
| Enterprise Value | $174,498.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.4 |
| Beta | 0.34 |
| Outstanding Shares | 6,868,000 |
Return
| Return on Equity | 321.16% |
|---|---|
| Return on Assets | -104.08% |
| Return on Invested Capital | -530.97% |
Valuation & Multiples
| P/E Ratio | -0.07 |
|---|---|
| PEG | -0.01 |
| Price to Sales | 0.05 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 0 |
| Enterprise Value to EBIT | 0 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | -65.84 |
| Debt to Equity | -1.01 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About IntegraGen S.A.
37 employees
CEO: Berengere Genin IntegraGen S.A. provides advanced human genome analysis services to academic researchers and life science businesses across France. Their comprehensive genomic offerings include transcriptomics, epigenomics, DNA sequencing, next-generati...